STXS (Stereotaxis) Marketable Securities: $0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STXS Stereotaxis Inc STXS
67 GF Score
Price $1.60
GF Value $2.34
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Stereotaxis Marketable Securities?

Stereotaxis STXS -2.44% 67 Marketable Securities is $0.00 Mil as of Mar. 2026. GuruFocus rates STXS with a GF Score™ of 67/100 and a GF Value™ of $2.34 (Possible Value Trap). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Stereotaxis's Marketable Securities for the quarter that ended in Mar. 2026 was $0.00 Mil.

Stereotaxis  (AMEX:STXS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Stereotaxis Marketable Securities Related Terms

Stereotaxis Marketable Securities Historical Data

* Premium members only.

The historical data trend for Stereotaxis's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stereotaxis Marketable Securities Chart

Stereotaxis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 19.84 0.00 0.00 0.00

Stereotaxis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STXS
67GF Score
Stereotaxis Inc STXS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stereotaxis Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Stereotaxis (STXS) has a Marketable Securities of $0.00 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Stereotaxis and its competitors.
Is Stereotaxis' Marketable Securities too high?
Stereotaxis' current Marketable Securities is $0.00 Mil. Overall, Stereotaxis has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Stereotaxis' Marketable Securities compare to PDEX and KRMD?
Stereotaxis' Marketable Securities of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Stereotaxis and its competitors. Stereotaxis's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stereotaxis stock overvalued right now?
Based on GuruFocus' analysis, Stereotaxis (STXS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.34, compared to a current price of $1.60 — trading 31.6% below its estimated fair value. The current Marketable Securities is $0.00 Mil. Stereotaxis' overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Stereotaxis (STXS), the current Marketable Securities is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stereotaxis (STXS) Overvalued in 2026?

Based on GuruFocus' analysis, Stereotaxis stock appears to be undervalued. The current stock price of $1.60 is trading 31.6% below its estimated GF Value™ of $2.34. GuruFocus considers Stereotaxis to be Possible Value Trap.

Key valuation signals for STXS:

  • Marketable Securities: $0.00 Mil
  • GF Value™: $2.34 vs. price of $1.60 (31.6% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the STXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stereotaxis Business Description

Other Exchanges RJR1:Germany
Address 710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
67GF Score

Get the complete analysis for STXS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.60
Price
$2.34
GF Value